As a result of the current Federal government funding situation, the information on this website may not be up to date or acted upon.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit

Updates regarding government operating status and resumption of normal operations can be found at

NCI Dictionary of Cancer Terms

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

The NCI Dictionary of Cancer Terms features 8,188 terms related to cancer and medicine.

We offer a widget that you can add to your website to let users look up cancer-related terms. Get NCI’s Dictionary of Cancer Terms Widget.

eltrombopag olamine
(el-TROM-boh-pag OH-luh-meen)
A drug used to treat thrombocytopenia (a lower-than-normal number of platelets in the blood) in patients with chronic immune thrombocytopenic purpura (a condition in which platelets are destroyed by the immune system). It is used in patients who did not get better with corticosteroids, immunoglobulins, or surgery to remove the spleen. It is also being studied in the treatment of other conditions and types of cancer. Eltrombopag olamine causes more platelets to be made in the bone marrow. It is a type of thrombopoietin receptor agonist. Also called Promacta.